The Therapeutic Potential of Targeting NIK in B Cell Malignancies

por Haselager, Marco V., Eldering, Eric
Publicado 2022

Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing?

por Haselager, Marco V., Kater, Arnon P., Eldering, Eric
Publicado 2020

JAK–STAT signalling shapes the NF‐κB response in CLL towards venetoclax sensitivity or resistance via Bcl‐XL

por Haselager, Marco V., Thijssen, Rachel, Bax, Danique, Both, Demi, De Boer, Francien, Mackay, Simon, Dubois, Julie, Mellink, Clemens, Kater, Arnon P., Eldering, Eric
Publicado 2023

In Vitro 3D Spheroid Culture System Displays Sustained T Cell-dependent CLL Proliferation and Survival

por Haselager, Marco V., van Driel, Bianca F., Perelaer, Eduard, de Rooij, Dennis, Lashgari, Danial, Loos, Remco, Kater, Arnon P., Moerland, Perry D., Eldering, Eric
Publicado 2023

Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation

por Kielbassa, Karoline, Haselager, Marco V., Bax, Danique J. C., van Driel, Bianca F., Dubois, Julie, Levin, Mark-David, Kersting, Sabina, Svanberg, Rebecka, Niemann, Carsten U., Kater, Arnon P., Eldering, Eric
Publicado 2023